Streetwise Reports' Article Archives — January 2024 back to current month (14)
Leadership Cuts Won't Slow This Biotech (01/26/2024)
While three executive officers have been cut from Kronos Bio Inc., it is still a Buy, according to an H.C. Wainwright & Co. report.
Pharma Co. Primed for Future Business (01/25/2024)
Analysts at Research Capital believe that Knight Therapeutics Inc. is primed to conduct future business development.
Healthcare Co. Exceeds Expectations in Performance (01/24/2024)
Sensus Healthcare Inc. released fourth-quarter financials that surpassed expectations, according to an H.C. Wainwright & Co. research note.
Innovator in Drug Policy Now Listed on the OTCQBA Venture Market (01/18/2024)
Safe Supply Streaming Co. Ltd. Announced that it is expanding availability for potential investors. Read on to see why this stock might represent an opportunity as drug policy changes.
Pharma Co. Invests in Clinical Psychedelics (01/17/2024)
ATAI Life Sciences N.V. has announced that it is investing in psychedelic treatments for Major Depressive Disorder and Alcohol Use Disorder. Read on to see why one analyst likes this company's stock.
Money Manager: The Year of Small Caps? (01/16/2024)
The president and chief executive officer of Toronto-based AlphaNorth Asset Management says his positive outlook on 2024 has not changed. In fact, it could be a great year for small caps.
Big Pharma's Looming Patents May Benefit One Biotech (01/10/2024)
Pharma stocks took big hits in recent years as many of its largest companies saw a looming "patent cliff" that could dry out profits from their big cash-cow drugs. This may be good for smaller pharma companies like one stock, which was one of Chen Lin's top picks for 2024.
Biotech Co.'s Sales Could Grow To US$310 Million in 2028 (01/10/2024)
Biotech Valneva SE announced that it had dosed the first participant in a Phase 2 pediatric trial evaluating its chikungunya vaccine candidate, according to an H.C. Wainwright & Co. report.
Telehealth Co. Adding Thousands to Large Contract (01/10/2024)
Reliq Health Technologies Inc. has signed a contract expansion with a large U.S. health plan, possibly adding as many as 50,000 new patients to its iUGO telehealth platform.
2024: Chen Leads With Biotech After Picking 2023's Top Stock (01/05/2024)
Asset manager Chen Lin was very happy with his picks from 2023, including one that ended up soaring 1,900%. See what the asset manager has lined up for the new year.
Market Correction and One Cash Rich Biotech (01/03/2024)
In late December, Ron Struthers pointed out that the S&P 500 made a double top and showed numerous over-bought conditions, so a correction is expected. He also shared one biotech that has been whacked down way below its cash value.
Boston Biotech Could Have Blockbuster Sales (01/03/2024)
Tango Therapeutics may have "blockbuster potential," noted an H.C. Wainwright & Co. report.
Pharma Co. Gets First US Patent for Repurposed Drug (01/02/2024)
Clinical-stage pharmaceuticals firm Algernon Pharmaceuticals Inc. has been issued a U.S. patent for the treatment of three related diseases with its investigational drug repirinast.
California-Based Pharma Co.'s Progress Offers Upside (01/02/2024)
While H.C. Wainwright & Co. lowered their price target, they still see upside for this pharmaceutical company.
More Archives
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
